IBM (NYSE:IBM) Posts Better-Than-Expected Sales In Q4 CY2025, Stock Soars

IBM (NYSE:IBM) Posts Better-Than-Expected Sales In Q4 CY2025, Stock Soars

By Radek Strnad
Publication Date: 2026-01-28 21:42:00

Technology and consulting giant IBM (NYSE:IBM) reported Q4 CY2025 results beating Wall Street’s revenue expectations , with sales up 12.1% year on year to $19.69 billion. Its non-GAAP profit of $4.52 per share was 5.4% above analysts’ consensus estimates.

Is now the time to buy IBM? Find out in our full research report.

  • Revenue: $19.69 billion vs analyst estimates of $19.21 billion (12.1% year-on-year growth, 2.5% beat)

  • Adjusted EPS: $4.52 vs analyst estimates of $4.29 (5.4% beat)

  • Adjusted EBITDA: $6.5 billion vs analyst estimates of $6.19 billion (33% margin, 5.1% beat)

  • 2026 Guidance: “We enter 2026 with momentum and in a position of strength, giving us confidence in our full-year expectations of more than 5 percent constant currency revenue growth and an increase of about $1 billion in year-over-year free cash flow”

  • Operating Margin: 21.1%, down from 22.3% in the same quarter last year

  • Free Cash Flow Margin: 32.9%, down from 35.1% in the same quarter…